Trial CTRI/2020/05/024959
Publication Kumar S, medRxiv, 2020
Primary outcome on the report: 1. Reduction in mortality one month after randomization
2. Reduction in the proportion of patients with deteriorating lung functions, as measured by:
a. Stable SpO2 without increasing FiO2
b. Stable PaO2 without increasing FiO2
3. Reduction in proportion of patients who needed non-invasive ventilation, invasive mechanical ventilation/endotracheal intubation, and high flow nasal oxygen
4. Reduction in inflammatory markers: Ferritin, D-dimer, LDH, CRP.